SecBot SecBot
144 ·Filed Nov 4, 2026

VCEL

Vericel Corp
NEUTRAL
Impact 2/10
Horizonimmediate Processed12d 10h ago SEC0001959173-26-007757
Form 144: notice of proposed sale of securities
Actionable Insight • Neutral

This is a routine insider sale by a director exercising stock options. The small size relative to market cap suggests no material signal. Monitor for any subsequent Form 4 filings to confirm the sale was executed, but no immediate read-through for the stock.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5
Entry
$51.78
T+0 close · Nov 4, 2026 · via day close
Latest settled
+10.89%
T+5 · $57.42 · next T+20 in 17d
Vs SPY
+7.60%
α at T+5
Latest observation
+11.61%
T+6 · FF3 residual α
  1. T+0 · Nov 5 $51.78entry
  2. T+1 · 11d ago +5.48%α +5.17% · $54.62
  3. T+5 · 5d ago +10.89%α +7.60% · $57.42
  4. T+7 · todayOpen
  5. T+20 · in 17d Pending
  6. T+60 · in 3mo Pending

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Director Robert L. Zerbe filed a Form 144 notice of intent to sell 2,500 shares of Vericel Corp common stock, with an approximate market value of $113,502. The sale is tied to a stock option exercise and is scheduled for the same day as the filing. This is a relatively small transaction relative to the company's $2.1B market cap and the director's likely holdings, and is routine in nature.

Key Facts

  • Insider: Robert L. Zerbe, MD, Director of Vericel Corp
  • Shares to be sold: 2,500 shares of common stock
  • Approximate value: $113,501.89
  • Sale date: November 4, 2026 (same day as filing)
  • Transaction type: Stock option exercise
  • Broker: Fidelity Brokerage Services LLC
  • Outstanding shares reference: 51,206,614

Financial Impact

2,500 shares at ~$45.40 per share, representing ~0.005% of shares outstanding and ~0.005% of market cap

dilution

Risk Factors

  • Insider sale could be perceived negatively if followed by additional director sales
  • Form 144 is an intent to sell; the actual sale may not occur

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
86% bullish (14 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001959173-26-007757
Document: 0001959173-26-007757-index.html0001959173-26-007757
Document: 0001959173-26-007757.txt0001959173-26-007757

Track record

30 reports on VCEL

Performance horizon

1 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +31.08% at T+60 after the May 7, 2026 report. 2 of 4 went positive at some point.

Filters
  1. Nov 13, 20263d ago 144 Neutral 2/10 Entry $56.96 Now $57.48 +0.91% settles Feb 11
  2. Nov 12, 20264d ago Insider Cluster Neutral 3/10 Entry $56.96 Now $57.48 +0.91% settles Feb 11
  3. Nov 12, 20264d ago 144 Neutral 1/10 Entry $57.42 Now $57.48 +0.10% settles Feb 10
  4. Nov 10, 20266d ago 144 Neutral 2/10 Entry $59.03 Now $57.48 −2.63% settles Feb 8
  5. Nov 9, 20267d ago 144 Neutral 2/10 Entry $59.03 Now $57.48 −2.63% settles Feb 8
  6. Nov 9, 20267d ago 144 Neutral 3/10 Entry $59.03 Now $57.48 −2.63% settles Feb 8
  7. Nov 9, 20267d ago Insider Cluster Neutral 2/10 Entry $59.03 Now $57.48 −2.63% settles Feb 8
  8. Nov 6, 202610d ago 144 Neutral 2/10 Entry $58.39 Now $57.48 −1.56% settles Feb 5
  9. Nov 6, 202610d ago Insider Cluster Neutral 2/10 Entry $58.39 Now $57.48 −1.56% settles Feb 5
  10. Nov 5, 202611d ago 144 Neutral 2/10 Entry $54.62 Now $57.48 +5.24% settles Feb 4
Showing 10 of 30

US Market Status

Market Closed · Opens in 6h 37m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 4, 2026